These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24532739)

  • 21. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries.
    Cui X; Gao L; Cao B
    Int J Infect Dis; 2020 Mar; 92S():S37-S40. PubMed ID: 32114201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latent TB (LTBI) treatment: Challenges in India with an eye on 2025: "To Treat LTBI or not to treat, that is the question".
    Rajpal S; Arora VK
    Indian J Tuberc; 2020 Dec; 67(4S):S43-S47. PubMed ID: 33308671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis.
    Han SS; Lee SJ; Yim JJ; Song JH; Lee EH; Kang YA
    PLoS One; 2019; 14(9):e0222810. PubMed ID: 31536577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON
    Hand J; Sigel K; Huprikar S; Hamula C; Rana M
    Transpl Infect Dis; 2018 Apr; 20(2):e12845. PubMed ID: 29359834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National position statement for the management of latent tuberculosis infection.
    Stock D;
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
    Ghassemieh BJ; Attia EF; Koelle DM; Mancuso JD; Narita M; Horne DJ
    Am J Respir Crit Care Med; 2016 Aug; 194(4):493-500. PubMed ID: 26890477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort.
    Kim HW; Min J; Choi JY; Shin AY; Myong JP; Lee Y; Yim HW; Jeong H; Bae S; Shim E; In H; Chun C; Kim G; Kang JY; Lee SS; Park JS; Kim JS
    J Korean Med Sci; 2021 Sep; 36(36):e246. PubMed ID: 34519187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE
    JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK; Rafiq A; Östör AJ
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of latent TB infection in areas of high TB prevalence.
    Sharma SK; Mohanan S; Sharma A
    Chest; 2012 Sep; 142(3):761-773. PubMed ID: 22948580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent tuberculosis infection (LTBI): a real host defence or a permanent threat?
    Sanduzzi A; Ponticiello A; Bocchino M; Perna F; Vatrella A
    Infez Med; 2016 Sep; 24(3):179-82. PubMed ID: 27668896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
    Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
    BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying components for programmatic latent tuberculosis infection control in the European Union.
    Sandgren A; Vonk Noordegraaf-Schouten JM; Oordt-Speets AM; van Kessel GB; de Vlas SJ; van der Werf MJ
    Euro Surveill; 2016 Aug; 21(34):. PubMed ID: 27589214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptance of interferon-gamma release assay by a high-risk urban cohort.
    O'Donnell MR; Coe A; Bliss C; Lee D; Tumilty S; Skolnik PR; Horsburgh CR; Cotton D; Saukkonen J
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1334-9. PubMed ID: 22283891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.